Seagen Inc
Change company Symbol lookup
Select an option...
SGEN Seagen Inc
CBLUY China BlueChemical Ltd
NIO NIO Inc
MSFT Microsoft Corp
LMT Lockheed Martin Corp
DD Dupont De Nemours Inc
DOW Dow Inc
CTVA Corteva Inc
CSCO Cisco Systems Inc
AAPL Apple Inc
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Seagen Inc. is a biotechnology company that develops and commercializes targeted therapies to treat cancer. The Company is engaged in the development and sale of pharmaceutical products on its own, behalf or in collaboration with others. The Company is commercializing ADCETRIS, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas; PADCEV or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, and TUKYSA, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. The Company also develops a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs. Its programs, including ADCETRIS and PADCEV, are based on its antibody-drug conjugate (ADC), technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. The Company's approved medicines include ADCETRIS, PADCEV and TUKYSA.

Postmarket

Last Trade
Delayed
$175.52
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$175.53
Day's Change
4.10 (2.39%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
176.40
Day's Low
169.81
Volume
(Above Average)
Volume:
643,263

10-day average volume:
563,836
643,263
  • Prev Close
    171.43
  • Today's Open
    171.27
  • Day's Range
    169.81-176.40
  • Avg Vol (10-day)
    563.8K
  • Last (time)
    3:59p ET 10/25/21
  • Last (size)
    100
  • 52-Wk Range
    133.20 - 202.60
    LowHigh
  • (12/18/20 - 05/04/21)
    13.36%
  • 38.5%
  • Market Cap
    31.9B
  • Shares Outstanding
    181.9M
  • 3.26
  • 52.61x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.8
  • 89.29
  • (% of float 09/30/21)
    1.78

Latest News

October 21, 2021
2:03 pm ET
Zacks
October 12, 2021
8:00 am ET
BusinessWire
8:00 am ET
PR Newswire
October 07, 2021
8:00 am ET
BusinessWire
September 28, 2021
8:00 am ET
BusinessWire
September 27, 2021
3:00 am ET
PR Newswire
3:00 am ET
BusinessWire
September 20, 2021
5:05 pm ET
BusinessWire
5:03 pm ET
BusinessWire
5:00 pm ET
BusinessWire
September 19, 2021
11:30 am ET
BusinessWire
September 09, 2021
8:00 am ET
BusinessWire
September 08, 2021
8:00 am ET
BusinessWire
July 17, 2021
7:45 pm ET
MarketWatch
May 17, 2021
6:41 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.